The Colorado NHLBI-supported StARR Program (Stimulating Access to Research in Residency) is pleased to announce the selection of one new scholar for the program. Congratulations to Shravya Pothula, MD.
The goal of the Colorado StARR Program – which is funded by an R38 award from the National Heart, Lung and Blood Institute at the NIH – is to recruit, train and retain outstanding clinician-investigators focused on translational research in heart, lung and blood disorders. The program supports a 1-2 year mentored research experience in heart, lung, and blood disorders for outstanding housestaff in Medicine, Pediatrics, and Surgery.
These newly awarded scholars will join the program’s current scholars embarking upon dedicated time for research during their residency training.
Shravya Pothula, MD
Beginning March 2025
The goal of Dr. Pothula’s STARR program is to identify key networks and pairings between the murine and analogous human samples through meta-genomics. Using a virtual cohort of patients from completed clinical trials from publicly available meta genomics consortia to better characterize which genetic mutations predispose certain phenotypes of different disease expression, progression, or severity of inflammation.
Caitlin Eason, MD
Beginning July 2024
Department of Surgery
Mentor: Chris Derderian, MD
Project: Effect of miRNAs and EVs on angiogenesis. Dr. Eason will be examining the effect of miRNA within extracellular vesicles on placental angiogenesis and by extension will establish whether this contributes to impaired fetal growth.
Lauren Maloney, MD
Beginning January 2025
Department of Pediatrics
Mentor: Sarah Taylor, MD
Project: Age-specific differences in the immune response to obstructive cholestasis. Dr. Maloney will be examining if age-based differences affect the immune cell response to bile acid toxicity in obstructive cholestasis and contribute to differences in disease phenotype in the neonate.
Ryen Ormesher, MD
Beginning June 2024
Department of Medicine
Mentor: Irina Petrache, MD
Project: Biomarkers in COPD predisposing to pulmonary hypertension. Dr. Ormesher will be examining if pulmonary vascular remodeling in COPD is associated with elevations of microRNA-126’ (miR126) cell type-specific targets.
Bo Chang “Brian” Wu, MD
Beginning July 2024
Department of Surgery
Mentor: Brett Reece, MD, MBA, FACS, FAHA, FACC
Project: Protective role of mitochondrial transplantation in an in vivo murine middle cerebral artery occlusion stroke model. Dr. Wu will be examining if pretreatment with mitochondrial transplantation may strengthen the neuronal cells against ischemia-reperfusion injury.
Jack Zakrzewski, MD
July 2023 – June 2025
Kellen Gil, MD
January 2024 – January 2026
Jayce Pangilinan, MD
July 2020 – June 2021
Elizabeth McGinn, MD
January 2022 – December 2022
August Longino, MD
July 2022 – June 2023
Alexander Heilman, MD
July 2022 – June 2023
Isabel Hardee, MD
January 2023 – December 2023
Lindsey Thomson, MD
March 2023 – February 2024
Natalie Longino, MD
April 2022 – April 2024
Kaitlyn McLeod, MD
April 2023 – April 2024
Katarina Leyba, MD
July 2023 – June 2024
David Schwartz, MD
Program Director
David.Schwartz@cuanschutz.edu
Jennifer Kemp, PhD
Associate Program Director
Jennifer.T.Kemp@cuanschutz.edu
Paul Wood, MA
Program Manager
Paul.Wood@cuanschutz.edu
Sarah Miller
Business Coordinator
sarah.h.miller@cuanschutz.edu